EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Auranofin and iodoquinol as promising repurposing drugs against filamentous fungi: antifungal activity and cellular alterations

Mariana Ingrid Dutra da Silva Xisto iD, Rodrigo Rollin-Pinheiro iD, Paloma Cristina Malfetano da Rosa, Johnatha de Souza Santos, Nicole Ferreira da Silva Irmão, Julia Almeida Abi Abib, Victor Pereira Rochetti, Yuri de Castro Almeida, Giulia Maria Pires Dos Santos Freitas, Jefferson Cypriano, Eliana Barreto-Bergter iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.03356-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Mariana Ingrid Dutra da Silva Xisto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Química Biológica de Microrganismos, Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Feder…. Hauptthemen laut MEDLINE: Antifungal Agents, Auranofin, Fungi, Drug Repositioning. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opportunistic fungal infections have become an increasing health threat, particularly in immunocompromised individuals, due to their high virulence, biofilm-forming capacity, and resistance to conventional antifungals. Given the limited therapeutic arsenal, drug repurposing represents a promising strategy for antifungal discovery. This study evaluated the antifungal activity and mechanisms of auranofin and iodoquinol against filamentous fungi listed as World Health Organization (WHO) priority pathogens, including Aspergillus fumigatus , Fusarium oxysporum , Scedosporium boydii , Lomentospora prolificans , Rhizopus oryzae , Mucor velutinosus , and Cunninghamella sp. Although Aspergillus flavus is not included in the WHO priority list, it was included in this study due to its clinical relevance as a major cause of aspergillosis and fungal rhinosinusitis. Auranofin displayed fungicidal activity against Aspergillus spp., L. prolificans , S. boydii , and R. oryzae , while iodoquinol exhibited potent but mainly fungistatic effects, with minimum inhibitory concentration values ranging from 0.625 to 20 µM. Both compounds inhibited early growth and reduced preformed biofilms by over 50% in biomass and metabolic activity. Stress susceptibility and fluorescence assays indicated that auranofin interferes with lipid homeostasis, cell wall integrity, and oxidative stress responses, whereas iodoquinol alters membrane lipids, mannose, and chitin distribution, suggesting multitarget surface effects. Scanning electron microscopy revealed consistent ultrastructural alterations, including hyphal deformation and increased extracellular matrix deposition in A. fumigatus and F. oxysporum treated with sub-inhibitory drug concentrations, corroborating the observed cellular stress responses. Drug interaction assays demonstrated additive or synergistic effects with voriconazole and amphotericin B, but not with posaconazole. Overall, auranofin and iodoquinol exhibit broad-spectrum antifungal activity, disrupt fungal morphology and physiology, and represent promising repurposed candidates for developing novel combination therapies against refractory mycoses. IMPORTANCE Mycoses caused by opportunistic fungi are an increasingly public health problem, particularly in immunocompromised individuals, due to their high virulence and resistance to conventional antifungals. The World Health Organization’s priority fungal pathogens list points out a variety of filamentous fungi, such as Aspergillus fumigatus , A. flavus , Fusarium oxysporum , Scedosporium boydii , Lomentospora prolificans , Rhizopus oryzae , Mucor velutinosus , and Cunninghamella sp. Given the limited therapeutic arsenal to combat them, drug repurposing represents a promising strategy for antifungal discovery. The present study evaluated the antifungal activity and some cellular alterations caused by auranofin and iodoquinol, which are already available in clinical settings to treat rheumatoid arthritis and infections by amoeba, respectively. The data presented in the study revealed that both drugs display a wide spectrum of action against different fungal pathogens, as well as contribute to highlight the potential of them as repurposing drugs to be investigated as alternatives for the treatment of mycoses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsAuranofinFungiDrug RepositioningMicrobial Sensitivity TestsHumansAspergillus fumigatusBiofilmsMycoses

Stichwörter der Autor:innen

antifungal therapyauranofinfungal infectionsiodoquinolrepurposing drugs

Substanzen

Antifungal AgentsAuranofin

Autor:innen und Institutionen

  • Laboratório de Química Biológica de Microrganismos, Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
  • Departamento de Microbiologia, Imunologia e Parasitologia, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
  • Unimicro, Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.

ORCID-Profile: Mariana Ingrid Dutra da Silva Xisto, Rodrigo Rollin-Pinheiro, Eliana Barreto-Bergter

Förderung

  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Xisto, M. I. D. S., Rollin-Pinheiro, R., da Rosa, P. C. M., Souza Santos, J., Irmão, N. F. S., Abib, J. A. A., Rochetti, V. P., de Castro Almeida, Y., Santos Freitas, G. M. P., Cypriano, J., & Barreto-Bergter, E. (2026). Auranofin and iodoquinol as promising repurposing drugs against filamentous fungi: antifungal activity and cellular alterations. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03356-25

Vancouver

Xisto MIDS, Rollin-Pinheiro R, da Rosa PCM, Souza Santos J, Irmão NFS, Abib JAA, et al. Auranofin and iodoquinol as promising repurposing drugs against filamentous fungi: antifungal activity and cellular alterations. Microbiology Spectrum. 2026. doi:10.1128/spectrum.03356-25

BibTeX
@article{Xisto2026,
  author = {Xisto, Mariana Ingrid Dutra da Silva and Rollin-Pinheiro, Rodrigo and da Rosa, Paloma Cristina Malfetano and Souza Santos, Johnatha de and Irmão, Nicole Ferreira da Silva and Abib, Julia Almeida Abi and Rochetti, Victor Pereira and de Castro Almeida, Yuri and Santos Freitas, Giulia Maria Pires Dos and Cypriano, Jefferson and Barreto-Bergter, Eliana},
  title = {Auranofin and iodoquinol as promising repurposing drugs against filamentous fungi: antifungal activity and cellular alterations},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.03356-25}
}
Kostenlos starten →